This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Nanohybrid Co., Ltd.. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Ji-Sun Jung: Innovator in Injectable Drug Carriers
Introduction
Ji-Sun Jung is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of drug delivery systems, particularly through his innovative work on injectable drug carriers. His research focuses on enhancing the efficiency of drug delivery while ensuring safety and efficacy.
Latest Patents
Ji-Sun Jung holds a patent for an injectable drug carrier comprising layered double hydroxide. This invention includes a non-toxic Layered Double Hydroxide (LDH) and pharmaceutically acceptable excipients. The method of preparing this injectable drug carrier involves synthesizing LDH with various compositions and controlling its size and shape to ensure it has no adverse effects in vivo. The solution obtained by dispersing the LDH in a solvent can be injected in vivo, allowing for the synthesis of nano-size LDH that does not affect blood vessels. The synthesized LDH has been shown to have no adverse effects even at a concentration of 400 mg/kg, contributing to the establishment of a drug delivery system that improves the delivery efficiency of specific drugs.
Career Highlights
Ji-Sun Jung is associated with Nanohybrid Co., Ltd., where he continues to advance his research in drug delivery systems. His work has garnered attention for its potential applications in medical treatments and therapies.
Collaborations
Ji-Sun collaborates with notable colleagues, including Taeun Park and Jin-Ho Choy, who contribute to the innovative research environment at Nanohybrid Co., Ltd.
Conclusion
Ji-Sun Jung's contributions to the field of injectable drug carriers highlight his commitment to improving drug delivery systems. His innovative approach and successful patent demonstrate the potential for advancements in medical technology.